Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Cohen Fred EDirector2017-05-16Sell8,25071,963$30.68253.11-3.5565,895 (Direct)
6,068 (By the Jane K Cohen Trust)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2017-05-03Sell5,000306,846$31.77158.85-6.8678,236 (Direct)
12,298 (Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
199,487 (Held by the Popovits 2010 Trust)
Shak StevenChief Scientific Officer2017-04-24Sell5,000331,103$31.46157.3-5.94331,103 (Direct)
Popovits Kimberly JPresident and CEO2017-04-03Sell5,000306,846$31.3156.5-5.4678,236 (Direct)
199,487 (Held by the Popovits 2010 Trust)
12,298 (Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2017-03-23Sell5,000331,103$31.26156.3-5.34331,103 (Direct)
Leber LauraChief Communication Officer2017-03-20Sell3,07214,627$31.8897.94-7.1814,627 (Direct)
Cole G BradleyCOO2017-03-08Sell5,71039,528$31.55180.15-6.2139,528 (Direct)
Popovits Kimberly JPresident and CEO2017-03-06Sell5,000308,210$31.09155.45-4.8278,236 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Shak StevenChief Scientific Officer2017-02-23Sell5,000331,103$29.36146.80.78331,103 (Direct)
Febbo Phillip G.Chief Medical Officer2017-02-16Sell2,49520,644$30.0975.07-1.6620,644 (Direct)
Cole G BradleyCOO2017-02-15Sell5,00039,728$291452.0339,728 (Direct)
Shak StevenChief Scientific Officer2017-01-23Sell5,000327,207$27.28136.48.47327,207 (Direct)
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.11.2735,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.05-3.3335,882 (Direct)
Popovits Kimberly JPresident and CEO2016-12-05Sell5,000289,594$30.02150.1-1.4359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-6.7414,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-6.69327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.4-0.335,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.442.4659,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.95-2.63327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.59-3.2735,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.04-0.326,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.1510.29327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.647.9535,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.28.63327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227029.51
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.352.4935,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.222.9629,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.17.91327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.211.0735,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8514.82327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.111.1635,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.925.6832,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61387.2134,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.018.7915,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28565.6831,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.316.36326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.085.6824,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-7.936,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-6.6327,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-12.0124,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.041.1327,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.190.8912,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.660.8924,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1213.6830,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9816.7330,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.127.4830,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9612.7730,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.167.4429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-5.4Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-2.7929,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-7.27Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-7.0729,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-0.9Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-5.6721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-7.336,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-11.57Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-10.31Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-9.0121,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-15.02Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-16.2922,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-18.356,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-3.87Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.082.8522,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-0.77Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-1.6622,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.28.15312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2113.5Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.7711.28Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.229.3922,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271899.59312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1110.7312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.313.37Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.487.1324,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.788.4322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6211.49Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3617.9423,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7512.72311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27819.5922,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.524.34311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.286.5922,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.586.1315,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.668.07311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27819.5924,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-6.09308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-1.37Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.515.0418,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.980.07308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-3.55Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-11.0121,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-15.266,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-14.43Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-11.321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-5.718,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-0.27308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-1.37Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-1.218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-12.27313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-13.76Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-9.0418,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-10.0621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-6.036,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-10.28318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-10.41Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-10.7421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-10.7421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-12.0919,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-16.25318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-14.5Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-12.4817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-12.4817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-11.2213,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-11.72323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-17.07Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-17.5317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-18.8613,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-18.17
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-19.4
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-18.716,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-19.79
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-19.88
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-21.057,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-20.44327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-18.82
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-17.426,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-13.83
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-14.037,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-14.73Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-17.8517,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-17.7812,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-1.37Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.486.4812,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.433.5712,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.586.52
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.45.197,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.54.192,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.963.9
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.535.12
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.085.5714,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.542.856,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.55.6817,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.76.1314,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.76.67333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.956.48Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28845.6817,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.686.296,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1210.29288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.79.84338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.2610.0436,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.528.31288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.28.63Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.16.4288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28845.6817,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.553.3914,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-10.55Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-16.06343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-12.4317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-12.411,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-14.9714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-12.35348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-6.63Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-15.4814,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-15.942,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-15.43353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-14.78Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-2.9514,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-17.586,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-13.58358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-14.87Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-16.39Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-17.6914,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-11.01363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-11.3Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-11.3Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-11.78Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-12.8913,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-12.46367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-8.28
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-10.4126,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-12.66
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-13.56Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-12.1717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-1.23
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-2.08Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.182.4913,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.694.01
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.424.896,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.655.94372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.956.48Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.985.7518,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.83.5Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-2.2813,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-1.63377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-1.6Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-1.6Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-1.63377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-4.7919,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-4.7Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-1.1713,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-1.73
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-1.73
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-1.73
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-0.74
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-0.74
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-0.74
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.191.82
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.61.82
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.711.82
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52853.82Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.75.15382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.385.45
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.85.45
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.15.45
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.650.85
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.850.75
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.340.75
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.762.8920,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.712.8920,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.613.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2412.25
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0912.25
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1312.25
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.613.03Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1811.7914,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.027.566,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.112Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.111.16Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.710.66382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28285.6817,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.857.447,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.27.76Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1513.68387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.88.43Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.483.57,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.635.23
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.726.98
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.165.23
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3114.2
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1614.07
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7814.2
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3513.5392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.986.78
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.666.78
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.538.19
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.198.67
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.488.67
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.88.63Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5210.45
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.511.247,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7414.07
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4914.07
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9420.87
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1634.016,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.835.98392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.629.61Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5532.637,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.242.19Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.234.017,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.128.54392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.821.07Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1517.147,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1517.147,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.911.876,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.057.17392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.28.151,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.76.677,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.69.11392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9114.218,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.815.181,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1212.98
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9212.98
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6812.94
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4513.037,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.618.23
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.068.19
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.38.19
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7515.81392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.4811.7419,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.210.99Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8314.117,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0813.63Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.916.59Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9216.08Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3216.86Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.213.98Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.559.96Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2521.02Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3221.82Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7924.38Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3221.82Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.415.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3813.68Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0817.28Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7818.08Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1218.08Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4416.27Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0615.18Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.715.18Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9226.51Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2126.51Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3527.16Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5131.45Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0831.45Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244433.29Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.239.91Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.239.91Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8740.5Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.636.17Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6533.71Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6830.3Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.231.75Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.630.7Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514069.09Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.164.02Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.461.96Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279112.11Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7895.96Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.498.99Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5397.14Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1599.8Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9299.8Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64104.63Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13104.63Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07105.92Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73105.92Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81103.79Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3103.79Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9497.4Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6197.4Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5696.35Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4299.26Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7699.26Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.597.27Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.2101.16Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58102.53Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23102.53Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.28100.61Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2130.99Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41126.74Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283109.12Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04110.6Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2487.52Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6886.45Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.289.56Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.890.78Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.475.4Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.575.09Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1475.3Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538952.13Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338653.32Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4852.6Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3252.13Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7949.22Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1573.55Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7973.55Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.671.74Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7868.99Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5273.96Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9473.96Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3472.64Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2571.54Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8769.38Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.647.07Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9545.12Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8444.91Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8846.2Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7846.05Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.254.03Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3347.65Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8848.02Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5847.95Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2543.29Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.144.91Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9243.22Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179839.77Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6540.04Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6542.74Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0443.15Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1447.07Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8542.47Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7448.1Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2748.1Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6848.1Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9148.1Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6551.51Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010047.95Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4451.82Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8851.74Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.851.82Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8851.82Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0452.37Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1751.9Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1184.82
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1184.82
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6261.96
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8967.27
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199555.74
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9164.66
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6264.66
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8164.66
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4564.66
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.647.07
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5252.06
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7251.36
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.151.36
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4651.36
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8251.36
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2850.05
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6416.18
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9717.1
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.852.53
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5554.68
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.637.5
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3643.64
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3643.64
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.241.92
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8552.45
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0246.7
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1153.71
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1153.71
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.860.82
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9848.92
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9848.92
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.647.58
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.746.7
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3245.33
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.431.45
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3530.52
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4835.8
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6529.04
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0330.41
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0825.01
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460622.07
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1224.54
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125240.9
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1553.63
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20247.95
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0448.54
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7748.62
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4648.62
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0548.62
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2864.48
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522557.81
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.253.55
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6471.84
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0857.06
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.844.48
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1546.27
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2231.05
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1228.6
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1928.99
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4815.86
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8930.58
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9328.1
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4134.5
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8428.26
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4427.49
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9246.78
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8449.14
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.450.2
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2850.28
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5951.2
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3757.73
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9248.62
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9952.21
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1639.71
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018855.65
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9254.44
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2968.51
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8981.31
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8781.31
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.181.31
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0981.31
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7778.36
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6678.36
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.978.36
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6278.36
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6190.9
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0290.9
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.690.9
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8490.9
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9590.9
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9590.9
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4478.04
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.581.42
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2471.34
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4372.44
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1561.87
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8761.87
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.361.87
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2861.87
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2661.87
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.261.25
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1563.57
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8863.57
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.463.48
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0963.57
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4163.57
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1662.76
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2650.74
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1459.6
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.259.6
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7359.6
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0459.6
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0459.6
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5762.14
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5662.14
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0462.14
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6762.14
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5562.14
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4463.3
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8155.98
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8537.12
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4537.12
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1737.12
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0737.12
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.734.68
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3843.64
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8843.64
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1343.64
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2643.64
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72110.6Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21110.6Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17110.6Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79146.58Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21146.58Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK